Stockscreener 앱 받기
8.00
2.96%
0.23
시간 외 거래:
8.00
전일 마감가:
$7.77
열려 있는:
$7.77
하루 거래량:
1.24M
Relative Volume:
1.62
시가총액:
$549.07M
수익:
-
순이익/손실:
$-96.66M
주가수익비율:
-3.7209
EPS:
-2.15
순현금흐름:
$-83.73M
1주 성능:
+5.54%
1개월 성능:
+45.19%
6개월 성능:
+81.41%
1년 성능:
-37.01%
1일 변동 폭
$7.4901
$8.0445
1주일 범위
$7.215
$8.25
52주 변동 폭
$2.86
$13.93
올레마 Stock (OLMA) Company Profile
명칭
Olema Pharmaceuticals Inc
전화
(415) 651-3316
주소
780 BRANNAN STREET, SAN FRANCISCO
OLMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
8.00 | 533.29M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.21 | 101.15B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.14 | 61.07B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.59 | 59.35B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.83 | 46.29B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.27 | 35.69B | 3.81B | -644.79M | -669.77M | -6.24 |
올레마 Stock (OLMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-12 | 재확인 | Citigroup | Buy |
| 2024-04-02 | 개시 | Goldman | Buy |
| 2024-01-30 | 개시 | Citigroup | Buy |
| 2023-07-21 | 개시 | Oppenheimer | Outperform |
| 2023-05-05 | 개시 | CapitalOne | Overweight |
| 2023-02-22 | 개시 | Credit Suisse | Outperform |
| 2022-07-06 | 재개 | Canaccord Genuity | Buy |
| 2022-06-09 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 개시 | H.C. Wainwright | Neutral |
| 2021-12-07 | 재개 | Cowen | Outperform |
| 2020-12-14 | 개시 | Canaccord Genuity | Buy |
| 2020-12-14 | 개시 | Cowen | Outperform |
| 2020-12-14 | 개시 | JP Morgan | Overweight |
| 2020-12-14 | 개시 | Jefferies | Buy |
모두보기
올레마 주식(OLMA)의 최신 뉴스
What indicators show strength in Olema Pharmaceuticals Inc.Weekly Stock Summary & Smart Money Movement Alerts - newser.com
Sentiment analysis tools applied to Olema Pharmaceuticals Inc.July 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Visual analytics tools that track Olema Pharmaceuticals Inc. performance2025 Price Action Summary & Low Drawdown Trading Strategies - newser.com
How sentiment analysis helps forecast Olema Pharmaceuticals Inc.Weekly Stock Summary & Safe Entry Zone Identification - newser.com
What’s the recovery path for long term holders of Olema Pharmaceuticals Inc.July 2025 Outlook & Intraday High Probability Setup Alerts - newser.com
Olema Pharmaceuticals Inc. stock prediction for this weekCPI Data & High Return Stock Watch Alerts - newser.com
Woodline Partners LP Boosts Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives $24.00 Consensus PT from Analysts - MarketBeat
What candlestick patterns are forming on Olema Pharmaceuticals Inc.Weekly Stock Report & Technical Confirmation Trade Alerts - newser.com
Applying chart zones and confluence areas to Olema Pharmaceuticals Inc.Weekly Investment Summary & Free Real-Time Volume Trigger Notifications - newser.com
What the charts say about Olema Pharmaceuticals Inc. todayMarket Trend Summary & Community Verified Trade Signals - newser.com
How moving averages guide Olema Pharmaceuticals Inc. trading2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com
Price momentum metrics for Olema Pharmaceuticals Inc. explained2025 Market Overview & Verified High Yield Trade Plans - newser.com
Can you recover from losses in Olema Pharmaceuticals Inc.M&A Rumor & Fast Entry High Yield Stock Tips - newser.com
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 7.2%Here's What Happened - MarketBeat
Olema Pharmaceuticals, Inc. $OLMA Shares Bought by Cubist Systematic Strategies LLC - MarketBeat
Invesco Ltd. Has $191,000 Stock Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Rating Upgraded by Zacks Research - MarketBeat
Price action breakdown for Olema Pharmaceuticals Inc.2025 Short Interest & Reliable Price Action Trade Plans - Newser
Should you hold or exit Olema Pharmaceuticals Inc. nowGap Up & Expert Curated Trade Setups - Newser
Does Olema Pharmaceuticals Inc. show high probability of reboundForecast Cut & High Win Rate Trade Alerts - Newser
OLMA Stock Soars 47% in September So Far on Second PFE Deal - Yahoo Finance
What data driven models say about Olema Pharmaceuticals Inc.’s futureInsider Buying & Verified Entry Point Detection - Newser
Olema Pharmaceuticals Inc. recovery potential after sell offAnalyst Downgrade & Weekly High Momentum Picks - Newser
Olema Pharmaceuticals (NASDAQ:OLMA) Upgraded at Zacks Research - Defense World
Intraday pattern recognizer results for Olema Pharmaceuticals Inc.Gap Down & Free AI Powered Buy and Sell Recommendations - Newser
PDT Partners LLC Buys Shares of 74,299 Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Pfizer-Olema Collaboration Targets Metastatic Breast Cancer - MSN
Heatmap analysis for Olema Pharmaceuticals Inc. and competitorsJuly 2025 Update & AI Optimized Trading Strategy Guides - Newser
HC Wainwright Issues Positive Forecast for OLMA Earnings - MarketBeat
Visualizing Olema Pharmaceuticals Inc. stock with heatmapsTrade Volume Report & Weekly Setup with ROI Potential - Newser
Published on: 2025-09-10 11:11:24 - Newser
Is Olema Pharmaceuticals Inc. showing signs of accumulationWeekly Stock Summary & Smart Money Movement Alerts - Newser
올레마 (OLMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.33%
0.05%
자본화:
|
볼륨(24시간):